Search the Newsreel

Sei Investments Co. Buys 448,174 Shares of Apyx Medical Corporation $APYX

Sei Investments Co. significantly increased its stake in Apyx Medical Corporation by 298.6% during the first quarter, purchasing an additional 448,174 shares to bring its total holdings to 598,255 shares, valued at $2.208 million. This move is part of broader institutional interest, with such …

Apyx Medical Corporation (NASDAQ:APYX) Given Consensus Recommendation of "Moderate Buy" by Brokerages

Apyx Medical Corporation (NASDAQ:APYX) has received a "Moderate Buy" consensus recommendation from seven brokerages, with an average 12-month price target of $6.60, significantly higher than its current $4.05 price. The company recently surpassed earnings estimates, reporting a smaller adjusted loss and higher revenue than …

Apyx Medical Corporation Revenue Breakdown – NASDAQ:APYX

Apyx Medical Corp (APYX) Stock News Today

This page provides an overview of Apyx Medical Corp (APYX) stock information, including its current trading price, market cap, and links to news, analysis, financials, and other company data. It notes that more earnings news will be coming soon for the company.

Apyx Medical (NASDAQ:APYX) Issues Quarterly Earnings Results, Beats Expectations By $0.01 EPS

Apyx Medical (NASDAQ:APYX) reported its quarterly earnings, beating analyst expectations with an adjusted loss of $0.07 per share against a projected $0.08 loss and revenue of $13.88 million. This revenue marked a 22% increase year-over-year, driven by a significant rise in surgical aesthetics sales …

Apyx Medical Corp (APYX) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Apyx Medical Corp (APYX), detailing its current earnings forecast score, average price target, and analyst ratings. Based on 5 analysts, the stock has a "Buy" trend with an average price target of $5.00. The company's expected revenue …

Apyx Medical Corp 2026: Revenue $13.88M, EPS ($0.07) — 10-Q Summary

Apyx Medical Corp (APYX) reported its 2026 quarterly results, with revenue increasing to $13.88M from $11.37M year-over-year. The company posted a net loss of ($3.24M) and a diluted loss per share of ($0.07), showing an improvement from the prior year. This performance was largely …

Apyx Medical Corp (APYX) (Q2 2026) Earnings Call Highlights: Revenue Surges 22% on Power Lipo ...

Apyx Medical Corp (APYX) reported a 22% increase in Q2 2026 revenue, reaching $13.9 million, primarily driven by a 28% surge in surgical aesthetics product sales and expanded FDA clearance for power liposuction on its Aion platform. Despite a net loss of $3.2 million, …

Apyx Medical Corporation (APYX) Stock Falls on Q2 2026 Earnings

Apyx Medical Corporation Reports Second Quarter 2026 Financial Results

Apyx Medical Corporation reported its second-quarter 2026 financial results, with total revenue of $13.9 million, primarily driven by a 28% growth in its Surgical Aesthetics segment. The company reaffirmed its full-year 2026 revenue guidance of $59.0 million to $60.0 million and highlighted the successful …

Apyx Medical Reports Q2 2026 Revenue of $13.9M, Surgical Aesthetics Up 28%

Apyx Medical announced its Q2 2026 financial results, reporting total revenue of $13.9 million, a 22% year-over-year increase, largely driven by a 28% growth in its Surgical Aesthetics segment. Despite a GAAP net loss of $3.2 million and an adjusted EBITDA loss of $0.7 …

Apyx Medical’s AYON System Gains FDA 510(k) Clearance for Power Liposuction

Apyx Medical reported Q2 2026 revenue of $13.9 million, a 22% year-over-year increase, primarily driven by 28% growth in its Surgical Aesthetics segment. The company also announced expanded FDA 510(k) clearance for its AYON Body Contouring System to include power liposuction and reaffirmed its …

Apyx Medical (APYX) Reports Q2 Loss, Beats Revenue Estimates

Apyx Medical (APYX) reported a Q2 loss of $0.07 per share, which was wider than the Zacks Consensus Estimate of a $0.06 loss but an improvement from the $0.09 loss reported a year ago. The company, a medical device maker, exceeded revenue estimates with …

Earnings call transcript: Apyx Medical tops Q2 2026 estimates, shares slip after hours

Apyx Medical (APYX) exceeded Q2 2026 revenue and earnings estimates, reporting a narrower loss of 7 cents per share and revenue of $13.9 million. Despite beating forecasts, shares slipped in after-hours trading due to investor concerns about the near-term margin outlook and cash usage. …

Apyx Medical Corp (APYX) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Apyx Medical Corp (APYX), detailing its current price momentum, support and resistance levels, and various technical indicators and moving averages. The stock currently has a price momentum score of 4.43 and is trading between a resistance level …

Apyx Medical Corp (APYX) Institutional Confidence

Apyx Medical Corp (APYX) has an institutional shareholding score of 3.00, placing it 130th out of 199 in the Healthcare Equipment & Supplies industry as of July 28, 2026. The institutional shareholding proportion is 46.73%, a slight decrease quarter-over-quarter. Bill Nygren | OAKMX is …

Apyx Medical Corp (APYX) Financial Health: Profitability & Balance Sheet Analysis

Apyx Medical Corp (APYX) has a financial score of 7.85 and ranks 64th in the Healthcare Equipment & Supplies industry, indicating stable financial health and high operating efficiency. The company reported a 32.45% year-over-

Apyx Medical Corporation to Participate in the Canaccord Genuity 46th Annual Growth Conference

Apyx Medical Corporation announced that its management will participate in the Canaccord Genuity 46th Annual Growth Conference on Tuesday, August 11, 2026, in Boston, MA. President and CEO Charlie Goodwin and CFO Matt Hill will hold a fireside chat and one-on-one meetings with investors. …

Apyx Medical Corp (APYX) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis of Apyx Medical Corp (APYX), noting its current valuation score of 9.25 and ranking within the Healthcare Equipment & Supplies industry. It highlights the company's P/E ratio, its deviation from recent highs and lows, and the absence of …

Apyx Medical CEO and CFO to Hold Aug. 11 Investor Fireside Chat

Apyx Medical announced that its management, President and CEO Charlie Goodwin and CFO Matt Hill, will participate in the Canaccord Genuity 46th Annual Growth Conference on August 11, 2026. They will hold a fireside chat and one-on-one investor meetings. The fireside chat will be …

Apyx Medical Corp (APYX) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Apyx Medical Corp (APYX), listing its major shareholders, their proportion of holdings, and institutional holdings over time. Key shareholders include Nantahala Capital Management, Archon Capital Management, and Royce Investment Partners. The data also presents a breakdown of …

Apyx Medical Corp (APYX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a revenue breakdown for Apyx Medical Corp (APYX), focusing on its regional revenue contribution. It shows that domestic revenue accounts for 73.43% ($38.80M) and international revenue for 26.57% ($14.04M). The article notes that relevant data for business segments have not yet …

Apyx Medical Corp (APYX) Dividends & Stock Splits: Historical Payouts and Event Timeline

The article provides dividend and stock split information for Apyx Medical Corp (APYX). It states that no dividend data is available, with a total of $0.00 USD distributed in dividends over the past five years. The page includes general stock information such as its …

Apyx Medical Corp (APYX) Income Statement

This article provides the quarterly and annual income statements for Apyx Medical Corp (APYX), detailing its financial performance. It includes comprehensive data on total revenue, cost of revenue, operating expenses, and net income, alongside various other financial metrics and their year-over-year changes across multiple …

APYX|Apyx Medical Corp|Price:4.140|

APYX|Apyx Medical Corp|Price:3.920|Chg%:+0.090

Apyx Medical Corp (APYX) closed at $3.920, up 2.35%, on July 24, 2026. The company, which specializes in advanced energy technology for cosmetic and hospital surgical markets, has healthy fundamentals and high growth potential, with its valuation considered fairly valued. Analysts have rated it …

Apyx Medical Schedules Live Q&A on Second-Quarter Results Aug. 6

Apyx Medical (NASDAQ: APYX) is set to release its second-quarter fiscal year 2026 financial results after market close on August 6, 2026. Management will host a conference call and Q&A session at 4:30 p.m. Eastern Time on the same day to discuss the results. …

Royce & Associates (APYX) reports 3.27M Apyx Medical shares under Schedule 13G/A

Royce & Associates has filed an amended Schedule 13G/A, reporting beneficial ownership of 3,274,064 shares of Apyx Medical Corporation (APYX) common stock, which represents 7.81% of the class. The firm maintains sole voting and dispositive power over these shares. Royce & Associates states that …

Earnings Update: Here's Why Analysts Just Lifted Their Apyx Medical Corporation (NASDAQ:APYX) Price Target To US$6.50

Apyx Medical Corporation (NASDAQ:APYX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$6.50

Apyx Medical Corporation Reports First Quarter 2026 Financial Results

Apyx Medical (APYX) Reports Q1 Loss, Tops Revenue Estimates

Earnings call transcript: Apyx Medical Q1 2026 beats expectations, stock surges